BRIM Biotechnology Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-436.45	-315.47	-688.02	-274.28	-105.45
Depreciation & Amortization	43.09	9.25	5.41	3.97	3.82
Loss (Gain) From Sale of Assets	-	-	-0.01	-	-
Loss (Gain) From Sale of Investments	-	-	-	-	-32.87
Loss (Gain) on Equity Investments	13.47	27.03	24.59	62.62	47.94
Stock-Based Compensation	36.02	39.17	47.78	35.32	7.07
Other Operating Activities	4.1	-13.82	-4.38	0.24	0.27
Change in Accounts Receivable	-0.47	-3.1	-1.41	-0.32	-0.01
Change in Inventory	0.16	-	-	-	-
Change in Accounts Payable	-0.66	-16.07	19.67	4.14	-31.77
Change in Unearned Revenue	0.83	-	-	-	-1.12
Change in Other Net Operating Assets	10.73	-6.23	-0.51	-3.57	-0.45
Operating Cash Flow	-329.17	-279.24	-596.89	-171.87	-112.57
Capital Expenditures	-0.8	-2.9	-2.26	-1.11	-0.78
Sale of Property, Plant & Equipment	-	-	0.01	-	-
Cash Acquisitions	4.4	-	-	-	-
Sale (Purchase) of Intangibles	-324.24	-77.08	-1.44	-0.11	-
Investment in Securities	970.04	-585.18	-747.63	23.84	119.34
Other Investing Activities	0.54	-0.32	-0.11	0	-0
Investing Cash Flow	649.94	-665.48	-751.43	22.63	118.56
Short-Term Debt Repaid	-16	-	-	-	-
Long-Term Debt Repaid	-9.57	-4.16	-4.18	-3.68	-3.6
Total Debt Repaid	-25.57	-4.16	-4.18	-3.68	-3.6
Net Debt Issued (Repaid)	-25.57	-4.16	-4.18	-3.68	-3.6
Issuance of Common Stock	-	503.64	1,463	591.16	314.33
Other Financing Activities	0.55	-	-	-	-
Financing Cash Flow	-25.02	499.49	1,458	587.49	310.73
Foreign Exchange Rate Adjustments	-0.08	-	-	-	-
Net Cash Flow	295.67	-445.24	110.01	438.24	316.72
Free Cash Flow	-329.97	-282.14	-599.15	-172.98	-113.35
Free Cash Flow Margin	-6010.38%	-84726.73%	-665723.33%	-32885.74%	-31485.83%
Free Cash Flow Per Share	-2.51	-2.42	-5.96	-2.43	-1.91
Cash Interest Paid	0.46	0.09	0.15	0.08	0.11
Cash Income Tax Paid	0.03	-	-0.07	-0.13	-0.05
Levered Free Cash Flow	-837.67	50.82	-371.06	-97.94	-81.3
Unlevered Free Cash Flow	-837.36	50.88	-370.97	-97.89	-81.23
Change in Working Capital	10.59	-25.39	17.75	0.25	-33.34

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.